New drug cocktail shows promise against Drug-Resistant TB
Disease control
Completed
This study tested a combination of three drugs—bedaquiline, pretomanid, and linezolid—in 109 people with extensively drug-resistant TB (XDR-TB) or multi-drug resistant TB (MDR-TB) that didn't respond to other treatments. Participants took the drugs for 6 to 9 months. The goal was…
Phase: PHASE3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC